GOLDMAN SACHS GROUP INC - PANDION THERAPEUTICS INC ownership

PANDION THERAPEUTICS INC's ticker is PAND and the CUSIP is 698340106. A total of 53 filers reported holding PANDION THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of PANDION THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$47,817,000
+12160.8%
796,286
+2935.0%
0.01%
Q4 2020$390,000
+84.0%
26,237
+41.9%
0.00%
Q3 2020$212,00018,4930.00%
Other shareholders
PANDION THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Boxer Capital, LLC 2,107,513$24,152,0000.84%
Logos Global Management LP 450,000$5,157,0000.66%
RA Capital Management 1,770,023$20,284,0000.37%
Redmile Group, LLC 1,119,600$12,831,0000.24%
Ikarian Capital, LLC 260,000$2,978,0000.22%
Orbimed Advisors 1,480,940$16,972,0000.21%
SPHERA FUNDS MANAGEMENT LTD. 95,000$1,089,0000.11%
Artal Group S.A. 145,000$1,662,0000.04%
Woodline Partners LP 75,101$861,0000.03%
BOOTHBAY FUND MANAGEMENT, LLC 29,883$342,0000.02%
View complete list of PANDION THERAPEUTICS INC shareholders